What is Bristol-Myers Squibb's proceeds from short-term borrowings?

Bristol-Myers Squibb (BMY) reported proceeds from short-term borrowings of $5.00M in Q3 2025.

How has Bristol-Myers Squibb's proceeds from short-term borrowings changed year-over-year?

Bristol-Myers Squibb's proceeds from short-term borrowings decreased by 94.7% year-over-year, from $95.00M to $5.00M.

What does proceeds from short-term borrowings mean?

Cash received from taking on new short-term loans.

Discontinued — last reported Q4 '20

Proceeds from short-term borrowings

Bristol-Myers Squibb Proceeds from short-term borrowings decreased by 91.4% to $5.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 94.7%, from $95.00M to $5.00M.

Analysis

StatementCash Flow Statement

SectionFinancing

CategoryLiquidity

SignalContext dependent

VolatilityModerate

First reportedQ1 2016

Last reportedQ4 2020

How to read this metric

Higher proceeds suggest a need for short-term financing, potentially due to capital expenditure spikes or debt refinancing.

Detailed definition

This metric tracks the total cash inflows from new short-term debt instruments, excluding commercial paper. It indicates...

Peer comparison

Commonly used by firms to bridge temporary gaps between cash inflows and outflows.

Metric ID: cf_proceeds_from_short_term_borrowings

Historical Data

14 periods

	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25
Value	$48.50M	$48.50M	$48.50M	$48.50M	-$30.00M	-$30.00M	-$30.00M	-$30.00M	$83.00M	$326.00M	$95.00M	$368.00M	$58.00M	$5.00M
QoQ Change	—	+0.0%	+0.0%	+0.0%	-161.9%	+0.0%	+0.0%	+0.0%	+376.7%	+292.8%	-70.9%	+287.4%	-84.2%	-91.4%
YoY Change	—	—	—	—	-161.9%	-161.9%	-161.9%	-161.9%	+376.7%	>999%	+416.7%	+343.4%	-82.2%	-94.7%

Range-$30.00M – $368.00M

CAGR-50.3%

Avg YoY Growth+149.9%

Median YoY Growth-88.5%

Current Streak2 quarters decline

Frequently Asked Questions

What is Bristol-Myers Squibb's proceeds from short-term borrowings?: Bristol-Myers Squibb (BMY) reported proceeds from short-term borrowings of $5.00M in Q3 2025.
How has Bristol-Myers Squibb's proceeds from short-term borrowings changed year-over-year?: Bristol-Myers Squibb's proceeds from short-term borrowings decreased by 94.7% year-over-year, from $95.00M to $5.00M.
What does proceeds from short-term borrowings mean?: Cash received from taking on new short-term loans.